Equities

Feedback PLC

FDBK:LSE

Feedback PLC

Health CareMedical Equipment and Services
  • Price (GBX)41.00
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change-48.75%
  • Beta1.3861
Data delayed at least 15 minutes, as of Oct 03 2024 09:20 BST.
More ▼

Profile data is unavailable for this security.

About the company

Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. The Company has a number of growth opportunities domestically and internationally across a range of markets.

  • Revenue in GBP (TTM)886.00k
  • Net income in GBP-3.49m
  • Incorporated1958
  • Employees24.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Deltex Medical Group plc1.78m-1.29m1.99m37.001.99m37.00
Image Scan Holdings Plc2.56m-11.06k3.76m14.003.76m14.00
Aptamer Group PLC1.04m-7.01m4.42m54.004.42m54.00
Surgical Innovations Group Plc12.54m-622.00k5.13m101.005.13m101.00
Feedback plc886.00k-3.49m5.47m24.005.47m24.00
Myhealthchecked PLC9.39m-1.04m6.90m10.006.90m10.00
Proteome Sciences plc4.04m-4.08m8.74m35.008.74m35.00
Cambridge Nutritional Sciences PLC9.77m-328.00k8.80m94.008.80m94.00
Rua Life Sciences PLC2.19m-1.44m9.00m33.009.00m33.00
Genincode PLC2.60m-5.94m9.29m36.009.29m36.00
Genedrive PLC272.00k-5.00m9.91m43.009.91m43.00
Renalytix PLC2.59m-35.24m13.70m80.0013.70m80.00
Verici DX PLC3.30m-3.67m15.65m19.0015.65m19.00
Data as of Oct 03 2024. Currency figures normalised to Feedback PLC's reporting currency: UK Pound GBX

Institutional shareholders

51.42%Per cent of shares held by top holders
HolderShares% Held
Unicorn Asset Management Ltd.as of 11 Sep 20232.43m18.21%
Octopus Investments Ltd.as of 11 Sep 20231.70m12.75%
Premier Fund Managers Ltd.as of 11 Sep 20231.27m9.50%
Mole Valley Asset Management Ltd.as of 11 Sep 2023820.25k6.15%
Herald Investment Management Ltd.as of 31 Dec 2023391.11k2.93%
Toscafund Asset Management LLPas of 31 Dec 2023250.00k1.88%
More ▼
Data from 23 Feb 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.